Wednesday, September 30, 2015 10:53:50 AM
The answer is because the started Tox KNOWING THEY NEEDED 2.5Kgs of material and also knowing they could not manufacture more than sub 200g quantities. But the natives were getting restless, so they started OVER A YEAR AGO with insufficient material to complete. They knew it, BASi knew it, but we didn't know it…not until much later when they had to say they were no longer using the existing (older) facility for manufacturing Tox material (as they had previously announced) and said they were doing it at the new facility. At least they will once they complete scale up (which they had previously announced as being completed).
This is not opinion of an anonymous poster, it is the factual timeline.
They broke it up into 3 pieces to make it appear progress was being made when in actuality, Tox is completely halted and has been for about a year.
If I say I can run a marathon and then announce I am going to actually run 26x 1 mile races, is that the same thing? How about if I say I have completed training to run a marathon, and then say, no, I am still working on training but can run 26x 1 mile races and will soon be able to run 4x 6.5 ,lie races and am working my way up to running a full 26 mile race, is my claim that I can run a marathon still valid?
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM